DEVELOPMENT OF COMPUTER-AIDED PRESCRIPTION SYSTEM FOR PERSONALIZED PHARMACOTHERAPY BASED ON THE PHAEMACOKINETICS AND PHARMACODYNAMICS

基于药代动力学和药效学的个体化药物治疗计算机辅助处方系统的开发

基本信息

  • 批准号:
    16390043
  • 负责人:
  • 金额:
    $ 7.87万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2006
  • 项目状态:
    已结题

项目摘要

The aim of this study was to develop the computer-aided system that assists dosage regiment optimization, prescription checking, proper use of drugs and distribution of drug information based on the pharmacokinetics and pharmacodynamics. We developed algorithms for personalized pharmacotherapy with regard to 1) dosage adjustment of quinolone antibiotics and angiotensin converting enzyme inhibitors in patients with renal dysfunction, 2) quantitative estimation of time-dependent effects of St.John's wort on the drug metabolism and excretion, 3) receptor occupancy-estimation of antipsychotics-induced adverse reactions, 4) dose regime recommendations to avoid drug interaction between new-quinolones and metal cations, 5) estimation of dosing interval dependency of the interaction between itraconazole and triazolam, 6) assessment of the effects of α1-adorenoceptor antagonists in benign prostatic hyperplasia based on the receptor occupancy theory, 7) avoiding piloerection associated with antidepressants, and 8) optimization of the dosage regimen of TS-1 (a combination preparation of tegafur, gimeracil and oteracil potassium). We also developed prototype systems for some of the above algorithms on a personal computer. For example, with regard to the above 1), we developed a computer-aided system that helps to optimize the dosage and dosing time in patients with arbitrary grade of renal function by adjusting the patient's plasma concentration profile to that of subjects with normal renal function.Moreover, we inquired, by pharmacists' questionnaire, the needs for the computer-aided systems for dosage optimization after patients' poor compliance or alteration of the dosage form, and developed the prototypes. We also inquired into the standardization of drug information with regard to the dosage formulation to develop a computer-aided prescription checking system. (260 words)
这项研究的目的是开发计算机辅助系统,该系统有助于剂量团优化,处方检查,适当使用药物以及基于药物治疗和药效学的药物信息分配。我们开发了针对肾功能障碍的患者的奎诺酮抗生素和血管紧张素转化酶抑制剂的剂量调整的个性化药物疗法的算法,2)圣约翰质量的时间依赖性估计对药物代谢和极端反应的时间依赖性,3)受体反应,4)剂量状态建议避免新喹诺酮与金属阳离子之间的药物相互作用,5)估算伊曲康唑和三唑仑之间相互作用的剂量间隔依赖性的估计,6)评估α1-亚种子概感拮抗剂在良性前列腺中的α1-亚种子拮抗剂的影响,基于受体的良性增生剂的良性和4),避免了与受体居住的养老机相关的,避免了8),避免了persive and persightant and persige and pility and pility persige and pil pilters and。 TS-1的方案(Tegafur,Gimeracil和Oteracil Potassium的组合制剂)。我们还为个人计算机上的某些算法开发了原型系统。 For example, with regard to the above 1), we developed a computer-aided system that helps to optimize the dosage and dosing time in patients with arbitrary grade of renal function by adjusting the patient's plasma concentration profile to that of subjects with normal renal function.Moreover, we invited, by pharmacists' questionnaire, the needs for the computer-aided systems for dosage optimization after patients' poor compliance or alteration of the dosage form, and developed the原型。我们还询问了有关剂量配方的药物信息的标准化,以开发计算机辅助处方检查系统。 (260个单词)

项目成果

期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Piloerection induced by replacing fluvoxamine with milnacipran
  • DOI:
    10.1111/j.1365-2125.2006.02838.x
  • 发表时间:
    2007-06-01
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Hori, Satoko;Matsuo, Nobuko;Sawada, Yasufumi
  • 通讯作者:
    Sawada, Yasufumi
適正な処方設計・調剤支援システムのための医薬品製剤情報の規格化[技術ノート]
适当处方设计和配药支持系统的药物配方信息标准化[技术说明]
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    佐田宏子;澤田康文;大谷壽一
  • 通讯作者:
    大谷壽一
モルヒネ製剤の剤形変更時の薬剤師の対応に関する研究
吗啡制剂改变剂型时药师的反应研究
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    久澄礼子;大谷壽一;堀 里子;澤田康文
  • 通讯作者:
    澤田康文
Pharmacokinetic modeling of the interaction between St John's wort and cyclosporine
圣约翰草和环孢菌素之间相互作用的药代动力学模型
Antacid interaction with new quinolones : Dose regime recommendations based on pharmacokinetic modeling of clinical data for ciprofloxacin, gatifloxacin and norfloxacin and metal cations.
抗酸剂与新喹诺酮类药物的相互作用:基于环丙沙星、加替沙星、诺氟沙星和金属阳离子临床数据的药代动力学模型的剂量方案建议。
共 16 条
  • 1
  • 2
  • 3
  • 4
前往

SAWADA Yasufumi的其他基金

Construction of a risk communication system to encourage the correct use of medicine in remote islands/rural communities
构建风险沟通体系,鼓励偏远海岛/农村社区正确用药
  • 批准号:
    25670069
    25670069
  • 财政年份:
    2013
  • 资助金额:
    $ 7.87万
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
    Grant-in-Aid for Challenging Exploratory Research
Development of support system for dosage adjustment to avoid drug-drug interactions caused by fluoropyrimidine anti-cancer drugs
开发剂量调整支持系统以避免氟嘧啶类抗癌药物引起的药物相互作用
  • 批准号:
    24390038
    24390038
  • 财政年份:
    2012
  • 资助金额:
    $ 7.87万
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
    Grant-in-Aid for Scientific Research (B)
Development of system to predict fetal toxicity based on PK/PD evaluation by transplacental transfer and effect of drugs
基于胎盘转移PK/PD评价和药物作用预测胎儿毒性系统的开发
  • 批准号:
    19390040
    19390040
  • 财政年份:
    2007
  • 资助金额:
    $ 7.87万
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
    Grant-in-Aid for Scientific Research (B)
Development of the strategy for the quantitative prediction and avoidance of drug-induced Parkinsonism based on pharmacokinetics and pharmacodynamics
基于药代动力学和药效学定量预测和避免药物性帕金森病的策略的制定
  • 批准号:
    11470513
    11470513
  • 财政年份:
    1999
  • 资助金额:
    $ 7.87万
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
    Grant-in-Aid for Scientific Research (B).
Quantitative analysis of Pharmacological effects of psychiatic drugs using neuronal cultured cells
利用神经元培养细胞定量分析精神药物的药理作用
  • 批准号:
    02671049
    02671049
  • 财政年份:
    1990
  • 资助金额:
    $ 7.87万
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
    Grant-in-Aid for General Scientific Research (C)
Quantitative relationship between in vivo receptor occupancy of psychotropic and the change of glucose utilization in brain
精神药物体内受体占有率与脑葡萄糖利用变化的定量关系
  • 批准号:
    63571017
    63571017
  • 财政年份:
    1988
  • 资助金额:
    $ 7.87万
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

生物炭还田钝化Cd耦合碳封存的剂量效应与机制研究及其调控优化
  • 批准号:
    42307028
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肺肿瘤低剂量率近距离放射治疗新型剂量优化方法研究
  • 批准号:
    12301543
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于大型加速器中子源装置的癌症治疗应用—BNCT中子束优化与剂量学关键问题研究
  • 批准号:
    12261131621
  • 批准年份:
    2022
  • 资助金额:
    200.00 万元
  • 项目类别:
    国际(地区)合作与交流项目
融合X射线剂量-光产额优化体系的XLCT精确发光模型研究
  • 批准号:
    12275355
  • 批准年份:
    2022
  • 资助金额:
    55.00 万元
  • 项目类别:
    面上项目
融合X射线剂量-光产额优化体系的XLCT精确发光模型研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目

相似海外基金

Thiazolino-Pyridone Compounds as Novel Drugs for Tuberculosis
噻唑啉-吡啶酮化合物作为结核病新药
  • 批准号:
    10698829
    10698829
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
    $ 7.87万
  • 项目类别:
Validation of Clinical Assays for Risk Stratification of Children With Pediatric Liver Neoplasms
小儿肝肿瘤儿童风险分层临床测定的验证
  • 批准号:
    10663695
    10663695
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
    $ 7.87万
  • 项目类别:
Theranostic for gastric cancer
胃癌的治疗诊断
  • 批准号:
    10699365
    10699365
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
    $ 7.87万
  • 项目类别:
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer
从学术界到商界:针对 HPV 相关癌症的新型疗法的开发
  • 批准号:
    10813323
    10813323
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
    $ 7.87万
  • 项目类别:
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms
开发一类针对碳青霉烯类耐药革兰氏阴性生物的新型肽抗生素
  • 批准号:
    10674131
    10674131
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
    $ 7.87万
  • 项目类别: